Strategic Performance and Operational Context
Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we’ll show you why it’s our #1 pick. Tap here.
Full-year revenue of $1.79 billion fell below guidance due to approximately $50 million in planned security deliveries being deferred beyond fiscal year-end because of Middle East conflict-related delays and site access constraints.
Management emphasized that deferred revenues remain firmly in the $1.9 billion record backlog and represent timing shifts rather than lost orders.
Security division performance was impacted by a $150 million year-over-year revenue headwind from the rolling off of major Mexico contracts, though this impact is expected to moderate significantly in fiscal 2027.
The Optoelectronics division achieved 9% revenue growth driven by broad-based demand and a vertically integrated model that captures business from customers diversifying global supply chains.
Healthcare division margins expanded to 10% from 1% year-over-year, reflecting the successful implementation of operational improvements and increased volume leverage.
The Radio Frequency (RF) business reached its highest level of customer engagement ever, driven by critical involvement in homeland defense over-the-horizon radar and ‘Golden Dome’ initiatives.
Strategic focus on recurring revenue led to 13% service revenue growth for the full year, supported by a massive installed base and the transition of legacy projects into long-term service phases.
Fiscal 2027 Outlook and Strategic Assumptions
Fiscal 2027 guidance assumes revenue growth of 5% to 8.1%, with performance expected to be strongest in the second half due to the timing of Middle East deliveries and new contract ramp-ups.
Management is taking a conservative approach to guidance by including only a portion of recent CBP IDIQ delivery orders, with the vast majority of those multi-year programs expected to impact fiscal 2028 and beyond.
Service revenues are projected to see strong double-digit growth in fiscal 2027 as more product installations roll off warranty and transition into high-margin service contracts.
Free cash flow is expected to exceed 100% of net income in fiscal 2027, supported by the anticipated collection of remaining receivables from the large Mexico security contract.
The company plans to continue heightened R&D investments to advance next-generation patient monitoring and security screening platforms while maintaining a downward trend in combined SG&A and R&D as a percentage of sales.
